Molecular Networks GmbH - Inspiring Chemical Discovery


Newsletter, December 2007

Today, Molecular Networks Announces the Release of

  isoCYP Version 1.0

for the Prediction of Isoform Specificity of Human Cytochrome P450 Substrates

isoCYP provides a fast method to predict the predominant human cytochrome P450 isoform by which a given organic compound is metabolized in phase I.

It has been specifically designed for drug-like molecules to support scientists in early stages of drug design and discovery projects to identify and eliminate compounds with inappropriate pharmacokinetc properties, e.g., in ADMET or risk assessment studies.

The underlying model in isoCYP includes the isoform specificities for cytochrome P450 3A4, 2D6 and 2C9 substrates.
Further Information
  • Product Details: Please refer to the isoCYP product page on Molecular Networks' web site for more details or directly contact us at info|at|molecular-networks.com.
  • Versions: isoCYP is available as GUI version and as XT version (GUI and batch mode version). In addition, a component for SciTegic® Pipeline Pilot™ is available.
  • Evaluation: Interested parties are invited to download a 30 days evaluation copy of isoCYP in the Download Area of Molecular Networks' web server, or to test it online at the isoCYP web service.
  • Special Introductory Offer: Save 10% of the regular 1st year license price of isoCYP (GUI version). This offer lasts for orders until February 29, 2008.

Molecular Networks GmbH Computerchemie - Erlangen - Germany
www.molecular-networks.com - info|at|molecular-networks.com

If you don't want to receive any further newsletters, please click on the following link to remove your email address from our mailing list: unsubscribe